Circular RNAs and RNA Splice Variants as Biomarkers for Prognosis and Therapeutic Response in the Liquid Biopsies of Lung Cancer Patients
Lung cancer, including non-small cell lung carcinoma (NSCLC), is the most frequently diagnosed cancer. It is also the leading cause of cancer-related mortality worldwide because of its late diagnosis and its resistance to therapies. Therefore, the identification of biomarkers for early diagnosis, pr...
Main Authors: | Florence de Fraipont, Sylvie Gazzeri, William C. Cho, Beatrice Eymin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-05-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fgene.2019.00390/full |
Similar Items
-
Splice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted Therapy
by: Cherine Abou-Fayçal, et al.
Published: (2017-02-01) -
Clinical Implications of Circulating Circular RNAs in Lung Cancer
by: Sae Seul Choi, et al.
Published: (2022-04-01) -
Identification of potential proteins translated from circular RNA splice variants
by: Aniruddha Das, et al.
Published: (2023-03-01) -
Circular RNAs Are Promising Biomarkers in Liquid Biopsy for the Diagnosis of Non-small Cell Lung Cancer
by: Lanxiang Huang, et al.
Published: (2021-05-01) -
Diagnostic efficacy of circular RNAs as noninvasive, liquid biopsy biomarkers for early detection of gastric cancer
by: Souvick Roy, et al.
Published: (2022-02-01)